RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Viking Therapeutics Stock

Viking Therapeutics Dividend 2024

Viking Therapeutics Dividend

0 USD

Viking Therapeutics Dividend yield

Ticker

VKTX

ISIN

US92686J1060

WKN

A12GD6

How much dividend does Viking Therapeutics 2024 pay?

According to the latest status from September 2024, Viking Therapeutics paid a total of 0 USD per share in dividends within the last 12 months. With the current Viking Therapeutics price of 70.47 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Viking Therapeutics Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Viking Therapeutics Dividend Safe?

Viking Therapeutics has been increasing the dividend for 0 years.

Over the past 10 years, Viking Therapeutics has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Viking Therapeutics's Dividend Distributions

Viking Therapeutics’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Viking Therapeutics's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Viking Therapeutics's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Viking Therapeutics’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Viking Therapeutics Aktienanalyse

What does Viking Therapeutics do?

Viking Therapeutics Inc. is a biotechnology company specializing in the development of drugs for the treatment of metabolic and endocrine disorders. It was founded in 2012 by Brian Lian, Ph.D., and is headquartered in San Diego, California. The company's business model focuses on targeting liver X receptors (LXRs) for the treatment of metabolic disorders. Viking Therapeutics aims to develop treatment options for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), as well as osteoporosis and hypothyroidism. Their lead products in development are VK2809 for NAFLD/NASH and VK5211 for osteoporosis. The company has a promising product pipeline and aims to improve the lives of millions of patients. Viking Therapeutics is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Viking Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Frequently Asked Questions about Viking Therapeutics stock

How much dividend does Viking Therapeutics pay?

Over the past 12 months, Viking Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Viking Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Viking Therapeutics?

The current dividend yield of Viking Therapeutics is .

When does Viking Therapeutics pay dividends?

Viking Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Viking Therapeutics?

Viking Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Viking Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Viking Therapeutics located?

Viking Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Viking Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Viking Therapeutics from 9/22/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/22/2024.

When did Viking Therapeutics pay the last dividend?

The last dividend was paid out on 9/22/2024.

What was the dividend of Viking Therapeutics in the year 2023?

In the year 2023, Viking Therapeutics distributed 0 USD as dividends.

In which currency does Viking Therapeutics pay out the dividend?

The dividends of Viking Therapeutics are distributed in USD.

Andere Kennzahlen von Viking Therapeutics

Our stock analysis for Viking Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Viking Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.